| Juan Carlos Armstrong, MD | |
|
4550 Cobb Parkway North Nw Ste 210, Acworth, GA 30101-4182 | |
| (770) 422-1372 | |
| (770) 423-9651 |
| Full Name | Juan Carlos Armstrong |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 30 Years |
| Location | 4550 Cobb Parkway North Nw Ste 210, Acworth, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639259666 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 049848 (Georgia) | Primary |
| 207RC0200X | Internal Medicine - Critical Care Medicine | 049848 (Georgia) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wellstar Paulding Hospital | Hiram, GA | Hospital |
| Wellstar Kennestone Hospital | Marietta, GA | Hospital |
| Wellstar Cobb Hospital | Austell, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wellstar Medical Group, Llc | 6709065402 | 1839 |
News Archive
OncoGenex Pharmaceuticals announced today that it has received written, scientific advice from the European Medicines Agency (EMA) on the company's development plan for OGX-011 (also known as custirsen) for the treatment of men with metastatic castrate-resistant prostate cancer (mCRPC). The input received from the Committee for Medicinal Products for Human Use (CHMP) at the EMA was in overall agreement with OncoGenex's development plan regarding the proposed preclinical studies and both the study designs and analyses for the Phase III trials.
Genetic variations in DNA repair patterns may increase risk of pancreatic cancer by as much as threefold or decrease it by as much as 77 percent, depending on the genes involved, according to a report published in the January 15, 2009, issue of Clinical Cancer Research, a journal of the American Association for Cancer Research.
A senior medical specialist has caused controversy over his comments regarding organ donations.
New preclinical research led by Wensheng Wei from Peking University in China has proposed the development of a circular RNA vaccine. Their findings showed the circular RNA vaccine creates neutralizing antibodies and strong T-cell responses against the receptor-binding domain of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein.
› Verified 4 days ago
| Entity Name | Emory Specialty Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407864168 PECOS PAC ID: 3476559782 Enrollment ID: O20061010000447 |
News Archive
OncoGenex Pharmaceuticals announced today that it has received written, scientific advice from the European Medicines Agency (EMA) on the company's development plan for OGX-011 (also known as custirsen) for the treatment of men with metastatic castrate-resistant prostate cancer (mCRPC). The input received from the Committee for Medicinal Products for Human Use (CHMP) at the EMA was in overall agreement with OncoGenex's development plan regarding the proposed preclinical studies and both the study designs and analyses for the Phase III trials.
Genetic variations in DNA repair patterns may increase risk of pancreatic cancer by as much as threefold or decrease it by as much as 77 percent, depending on the genes involved, according to a report published in the January 15, 2009, issue of Clinical Cancer Research, a journal of the American Association for Cancer Research.
A senior medical specialist has caused controversy over his comments regarding organ donations.
New preclinical research led by Wensheng Wei from Peking University in China has proposed the development of a circular RNA vaccine. Their findings showed the circular RNA vaccine creates neutralizing antibodies and strong T-cell responses against the receptor-binding domain of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein.
› Verified 4 days ago
| Entity Name | Wellstar Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558664003 PECOS PAC ID: 6709065402 Enrollment ID: O20110127000374 |
News Archive
OncoGenex Pharmaceuticals announced today that it has received written, scientific advice from the European Medicines Agency (EMA) on the company's development plan for OGX-011 (also known as custirsen) for the treatment of men with metastatic castrate-resistant prostate cancer (mCRPC). The input received from the Committee for Medicinal Products for Human Use (CHMP) at the EMA was in overall agreement with OncoGenex's development plan regarding the proposed preclinical studies and both the study designs and analyses for the Phase III trials.
Genetic variations in DNA repair patterns may increase risk of pancreatic cancer by as much as threefold or decrease it by as much as 77 percent, depending on the genes involved, according to a report published in the January 15, 2009, issue of Clinical Cancer Research, a journal of the American Association for Cancer Research.
A senior medical specialist has caused controversy over his comments regarding organ donations.
New preclinical research led by Wensheng Wei from Peking University in China has proposed the development of a circular RNA vaccine. Their findings showed the circular RNA vaccine creates neutralizing antibodies and strong T-cell responses against the receptor-binding domain of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Juan Carlos Armstrong, MD 55 Whitcher St Ne, Suite 160, Marietta, GA 30060-1155 Ph: (770) 422-1372 | Juan Carlos Armstrong, MD 4550 Cobb Parkway North Nw Ste 210, Acworth, GA 30101-4182 Ph: (770) 422-1372 |
News Archive
OncoGenex Pharmaceuticals announced today that it has received written, scientific advice from the European Medicines Agency (EMA) on the company's development plan for OGX-011 (also known as custirsen) for the treatment of men with metastatic castrate-resistant prostate cancer (mCRPC). The input received from the Committee for Medicinal Products for Human Use (CHMP) at the EMA was in overall agreement with OncoGenex's development plan regarding the proposed preclinical studies and both the study designs and analyses for the Phase III trials.
Genetic variations in DNA repair patterns may increase risk of pancreatic cancer by as much as threefold or decrease it by as much as 77 percent, depending on the genes involved, according to a report published in the January 15, 2009, issue of Clinical Cancer Research, a journal of the American Association for Cancer Research.
A senior medical specialist has caused controversy over his comments regarding organ donations.
New preclinical research led by Wensheng Wei from Peking University in China has proposed the development of a circular RNA vaccine. Their findings showed the circular RNA vaccine creates neutralizing antibodies and strong T-cell responses against the receptor-binding domain of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein.
› Verified 4 days ago
Dr. Chinedu Patrick Nweke, M.D Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4450 Calibre Xing Nw Ste 1126, Acworth, GA 30101 Phone: 470-227-8130 Fax: 470-747-7588 | |
Dr. Joshua Foromera, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 4550 Cobb Parkway North Nw Ste 210b, Acworth, GA 30101 Phone: 470-267-1760 | |
Dr. Carroll G Odem, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 6380 Bells Ferry Rd Ste 107, Acworth, GA 30102 Phone: 404-989-7384 Fax: 855-604-0965 | |
Bhawna Khanna, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3950 Cobb Parkway Nw, Suite 601, Acworth, GA 30101 Phone: 770-874-7623 Fax: 770-874-7627 | |
Dr. Ebon Anthony Bourne, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4550 Cobb Parkway North Nw, Suite 205, Acworth, GA 30101 Phone: 770-917-8160 Fax: 770-529-1167 | |
Dr. May Amanukpo Robinson, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1862 Hickory Creek Ct Nw, Acworth, GA 30102 Phone: 404-579-3999 | |
Dr. Milicent Eva Young, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 4550 Cobb Parkway North Nw Ste 201a, Acworth, GA 30101 Phone: 770-974-4655 Fax: 770-974-7534 |